Abacavir/Lamivudine Plus Rilpivirine Is An Effective And Safe Strategy For Hiv-1 Suppressed Patients: 48 Week Results Of The Simriki Retrospective Study (Vol 11, E0164455, 2016)Jesus Troya,Pablo Ryan,Esteban Ribera,Daniel Podzamczer,Victor Hontanon,Jose Alberto Terron,Vicente Boix,Santiago Moreno,Pilar Barrufet,Manuel Castano,Ana Carrero,Maria Jose Galindo,Ignacio Suarez-Lozano,Hernando Knobel,Miguel Raffo,Javier Solis,Maria Yllescas,Herminia Esteban,Juan Gonzalez-Garcia,Juan Berenguer,Arkaitz ImazPLOS ONE(2017)引用 0|浏览3暂无评分AI 理解论文溯源树样例生成溯源树,研究论文发展脉络Chat Paper正在生成论文摘要